The type X\'II collagen al chain has been identified as a component of the type I hemidesmosome, and is thus thought to play a role in extracellular matrix ECM maintenance and signal transduction between the cell and the EC\I. We examined the expression of type XVII collagen al chain mRNA in the mouse heart by Northern blot analysis and determined the sequential changes of its expression in different developmental stages of the heart using the reverse transcriptase-polymerase chain reaction (RT-PCR) method..Vorthem blotting: Total RNA was extracted from 10 adult mouse hearts by the guanidine/cesium method. Hybridization was performed with mouse cDNA for a1 XVIL collagen. RT-PCP,• Total RNA was extracted from 7 embryos . 4 neonates and 8 adult mice. Reverse transcription was performed using oligo-dT primer and \I\ILV. Amplification was carried out in a1 XVIIi collagen and glyceraldehyde 3-phosphate dehvdrogenase (GAPDH). GAPDH served as an internal control. Northern blotting revealed a 5.6 kb signal that was identical to that of the a1 XVII) of skin and transformed keratinocyte reported previously. The sequences of the PCR products were also identical to those reported. The normalized expression ratios of al XVII) were 0.91 ± 0.20 in the embryonic heart, 0.36 ± 0.20 in the neonatal heart and 0.96 ± 0.21 in the adult heart. In conclusion, we identified the expression of type XVII collagen al chain mRNA in the mouse heart, suggesting that the type I hemidesmosome is located in the heart. The results of the RT-PCR at different developmental stages of the heart suggest that type XVII collagen contributes not only to cardiogenesis in the embryonic stage but also to maintenance of architecture and function in the adult heart. (Jpn Heart J 1998; 39: 211-220) 
The molecular aspects of hemidesmosomes have recently been clarified.') Two types of hemidesmosome have been identified: types I and II.6-8) The type I hemidesmosome, which is the typical hemidesmosome, is composed of 5 major distinct polypeptides with molecular masses of 500, 230, 200, 180 and 120 kDa, sequentially termed hemidesmosome 1 to hemidesmosome 5 (HD1-HD5). [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] The type II hemidesmosome consists of HD1, HD3 and HD5 molecules but lacks HD2 and HD4. The type II hemidesmosome is found in certain endothelial cells and glial cells. ') HD4 is a 180 kDa bullous pemphigoid antigen (formerly designated as BPI 80) that was initially isolated as an autoantigen in autoimmune subepidermal blistering disease, bullous pemphigoid.16,1 ') The HD4 (BPI 80) molecule is a transmembrane protein with a C-terminal extracellular segment consisting of 15 interrupted collagenous domains, and has been recently designated as type XVII collagen."') Li et al."') recently cloned the type XVII al chain. We hypothesized that type XVII collagen is expressed in the heart. Although the distribution of the expression of HD4 (BP 180) in other tissues has been reported,") there have been no reports regarding the expression of type XVII collagen in the heart. Accordingly, we examined the expression of type XVII collagen al chain mRNA in mouse hearts by Northern blot analysis, and identified the sequential changes of its expression in different developmental stages of the heart using the reverse transcriptase-polymerase chain reaction (RT-PCR) method.
MATERIALS AND METHODS

Materials
A total of 10 BALb/c mice (Okayama University Medical School Animal Center, Okayama, Japan) were used to determine the expression of type XVII a l [a l (XVII)] chain mRNA expression by Northern blotting. To examine the expression at different stages of mouse heart development by RT-PCR, 7 mice at the embryonic stage (day-18 to -20), 4 neonatal (1-day old), and 8 adults (2-months old) hearts were used.
Methods
Northern blotting
Isolation of KV4. Total RNA was extracted from the hearts by the guanidium isothiocyanate-cesium chloride density gradient centrifugation method reported previously. 202'' The recovery of RNA was calculated from the optical densities at 260 nm and the purity of extracted RNA confirmed from the optical density ratio of 260 nm/280 nm. A 1 pg mRNA, which was purified from 100 µg total RNA extracted from the heart, and 30 µg each of total RNA extracted from tongue and from PAM cells were electrophoresed on 0.8% agarose-formaldehyde gels containing 2.2M formaldehyde. They were then transferred to Hybond N nylon membranes (Amersham, Arlington, Heights, IL, USA)" and then to Hybond N nylon membranes (Amersham).222' After ultraviolet cross-linking, filters were prehybridized in a solution containing 50% formamide, 6 x SSC (1 X SSC; 300 nM/L sodium chloride and 30 nM/l sodium citrate, pH 7.0), Denhardt's solution (i.e., 0.1% bovine serum albumin, 0.1% Ficoll 400 and 0.1% polyvinylpyrrolidone), 0.5% sodium dodecyl sulfate (SDS) and 20 µg/ml of heated denatured salmon sperm deoxyribonucleic acid at 55°C for 3 hours.
Hybridization. Recombinant plasmids complementary to mouse al (XVII) containing 370 base pairs (bp), which were prepared according to the methods previously reported '21 were used for making cDNA probe. The electrophoresed mR_ As on filters were hybridized with a 32P-labeled mouse al (XVII) complementary deoxyribonucleic acid (cDNA) probe in the same solution as that used for prehybridization at 55°C for 24 hours. The cDNAs were labeled with 32P dCTP by the random primer extension method reported by Feinberg and Volgelstein,23, and Church and Gilbert2l using the Amersham Multiprime DNA labeling kit. After hybridization, the filters were washed under stringent conditions: once with 3 x SCC containing 0.1% SDS at 55°C for 30 min, once with 2 x SSC containing 0.1% SDS at 55°C for 30 min, and once with 0.1 x SSC containing 0.1 % SDS at room temperature for 15 min. Radio-labeled filters were exposed to x-ray film (Kodak XAR, Eastman Kodak Co., Rochester, NY, USA) at -70°C with an intensifying screen.
RT-PCR
Isolation of R!\':-1. We employed RT-PCR to examine the relative expression of the al(XVII) chain mRNA in the hearts examined, because a relatively small amout of RNA could be extracted from the embryonic hearts. Total RNA was extracted from the mouse heart at different developmental stages using a RNAZo11 " kit (Cinna Biotecx Lab., Houston, TX, USA) according to the established method.23 Approximately >30 yg RNA was obtained from the heart at each stage (embryonic, neonatal, and adult). First strand cDNA was synthesized using 2 µg of total RNA extracted from each stage and used for the template/ reaction in 20 yl of a solution containing 2.5 mM dNTPs (Pharmacia Biotech, Tokyo, Japan), 125 units of Moloney murine leukemia virus reverse transcriptase (USBTM, Cleveland, OH, USA), 20 units of RNasin (Toyobo, Osaka, Japan) and 100 pmol of Oligo (dT)15 primer (Promega, Madison, WI, USA). A 2.5 µ1 aliquot of cDNA material with Taq DNA polymerase (Toyobo) was used to amplify the al(XVII) chain mRNA by PCR. The primers specific for al(XVII) mRNA and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were designed by Oligo 4.0 (National Biosciences Inc., Plymouth, MN, USA) and synthesized by a Model 394 DNA Synthesizer (Perkin Elmer Japan, Urayasu, Chiba, Japan). Number of PCR Cycles. Initially, PCR was performed with 10 cycles and the number of cycles was then increased by 2 cycles. The densities of the amount of PCR products were plotted against the number of cycles. Finally, the number of cycles was determined as the number that showed a linear trajectory before it reached the maximum plateau. PCR determinations for all samples were performed at the same time using a Thermal CyclerTM (MJ Research Inc., Watertown, MA, USA). Condition for PCR. The specific primers and the distance between the forward and reverse primers were as follows.
al ( Southern blotting. The electrophoresed products on 1 % agarose gels were also blotted and fixed onto nylon filters (HybondTM-N+; Amersham, Little Chalfout, Buckinghamshire, UK) with 0.4 N NaOH and hybridized with the complementary DNA probe. Probes were labelled routinely to a specific activity of 1 x 106
Sequencing of PCR Product. RT-PCR product from total RNA of PAM cells was ligated into the pCRT''t 2.1 vector using TA cloning kit (Invitrogen Corp., San Diego, CA, USA). Nucleotide sequence analysis was perfomed by the dideoxychain termination technique. The fluorescence labeled dye-terminator method and an automatic sequencer (Model 373S, Perkin Elmer Japan) were used.
Quanti ication. The bands of electrophoresed amplified products hybridized for amplified a l (XVII) mRNA were quantified densitometrically using a Fast Scan Densitometer (Molecular Dynamics Co., Sunnyvale, CA, USA) and normalized relative to the GAPDH band density.
Statistical analysis
To compare the expression of al(XVII) chain mRNA in the embryonic, neonatal and adult hearts, analysis of variance with Sheffe's F-test was employed for the comparison of group data. All values are expressed as mean ± SD, and a p value <0.05 was accepted as statistically significant.
RESULTS
Northern blotting
The RNA extracted from the adult hearts was positively hybridized with al(XVII) cDNA by Northern blotting. The exposed band is shown in Figure 1 . The hybridized signals were positioned at 5.6Kb with a single band. The signals were identical to those in the controls (PAM cell and tongue). PCR demonstrated that al(XVII) collagen mRNA was expressed in all of the stages of the heart examined, i.e., the embryonic, neonatal and adult hearts (Figure 2) . The normalized expression ratios of al(XVII) to GAPDH were 0.91 ± 0.20 (n = 7) in the embryonic heart, 0.36 ± 0.20 (n = 4) in the neonatal heart and 0.96 ± 0.21 (n = 8) in the adult heart (Figure 3 ). The expression of al(XVH) chain mRNA in the neonatal hearts was significantly lower than that in the embryonic or adult hearts. No differences in its expression between the embryonic and adult hearts were observed. HD4 (BP180) has 3 structural domains; an intercellular domain, a cellmembrane spanning domain and an extracellular collagenous domain.-') The amino acid sequence of HD4 meets the criteria of collagenous protein and was designated as type XVII collagen.") The type XVII collagen al chain contains of 13 distinct collagenous domains with noncollagenous interruptions. The high interrupted triple helices are similar to those in types IV and VII collagen. The amino-terminal of type XVII collagen is connected to a cell-membrane spanning noncollagenous domain. Based on these characteristics of type XVII collagen and its location in the skin, type XVII collagen is thought to serve as an attachment site for the other ECM components, especially the basement membrane components. The basement membrane component plays the important role of providing cue signals for cell proliferation and differentiation.") In light of these biological findings in hemidesmosomes, the present evidence of the expression of type XVII collagen mRNA in the heart suggests that type XVII collagen contributes to the cell-to-ECM attachment in the hearts. 
